Two grants totaling $30 million a year for 3 years support efforts to design vaccines, drugs for understudied virus families
Scientists at Washington University School of Medicine in St. Louis are laying the groundwork to rapidly respond to potential future pandemics caused by viruses from five understudied families. The effort, the aim of which is to develop strategies and tools to produce vaccines and antibody-based therapies in advance of future pandemic threats, is supported by two major grants from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), which together will add up to more than $90 million in funding over the next three years.